Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997 - PubMed (original) (raw)
. 1997 Aug 22;46(33):765-6.
- PMID: 9272582
Free article
Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997.
Free article
Erratum in
- MMWR Morb Mortal Wkly Rep 1997 Sep 12;46(36):851
Abstract
Staphylococcus aureus is one of the most common causes of both hospital- and community-acquired infections worldwide, and the antimicrobial agent vancomycin has been used to treat many S. aureus infections, particularly those caused by methicillin-resistant S. aureus (MRSA). In 1996, the first documented case of infection caused by a strain of S. aureus with intermediate levels of resistance to vancomycin (VISA; minimum inhibitory concentration [MIC]=8 microg/mL) was reported from Japan. This report describes the first isolation of VISA from a patient in the United States, which may be an early warning that S. aureus strains with full resistance to vancomycin will emerge.
Similar articles
- Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997 Sep 5;46(35):813-5. MMWR Morb Mortal Wkly Rep. 1997. PMID: 9310213 - Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1165-7. MMWR Morb Mortal Wkly Rep. 2000. PMID: 11266244 - Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR. Smith TL, et al. N Engl J Med. 1999 Feb 18;340(7):493-501. doi: 10.1056/NEJM199902183400701. N Engl J Med. 1999. PMID: 10021469 - Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
Appelbaum PC. Appelbaum PC. Int J Antimicrob Agents. 2007 Nov;30(5):398-408. doi: 10.1016/j.ijantimicag.2007.07.011. Epub 2007 Sep 20. Int J Antimicrob Agents. 2007. PMID: 17888634 Review. - Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
Fridkin SK. Fridkin SK. Clin Infect Dis. 2001 Jan;32(1):108-15. doi: 10.1086/317542. Epub 2000 Dec 13. Clin Infect Dis. 2001. PMID: 11118389 Review.
Cited by
- Update on bacterial pathogens: virulence and resistance.
Cercenado E, Garau J, Almirante B, Ramón Azanza J, Cantón R, Cisterna R, María Eiros J, Fariñas C, Fortún J, Gudiol F, Mensa J, Pachón J, Pascual Á, Luis Pérez J, Rodríguez A, Sánchez M, Vila J. Cercenado E, et al. Enferm Infecc Microbiol Clin. 2008 Apr;26:3-21. doi: 10.1016/S0213-005X(08)76378-X. Epub 2009 May 13. Enferm Infecc Microbiol Clin. 2008. PMID: 38620184 Free PMC article. - Combining CRISPR-Cas12a-Based Technology and Metagenomics Next Generation Sequencing: A New Paradigm for Rapid and Full-Scale Detection of Microbes in Infectious Diabetic Foot Samples.
Chen Y, Shi Y, Zhu W, You J, Yang J, Xie Y, Zhao H, Li H, Fan S, Li L, Liu C. Chen Y, et al. Front Microbiol. 2021 Oct 7;12:742040. doi: 10.3389/fmicb.2021.742040. eCollection 2021. Front Microbiol. 2021. PMID: 34690988 Free PMC article. - Untargeted Metabolomic Profiling, Multivariate Analysis and Biological Evaluation of the True Mangrove (Rhizophora mucronata Lam.).
Sadeer NB, Rocchetti G, Senizza B, Montesano D, Zengin G, Uysal A, Jeewon R, Lucini L, Mahomoodally MF. Sadeer NB, et al. Antioxidants (Basel). 2019 Oct 16;8(10):489. doi: 10.3390/antiox8100489. Antioxidants (Basel). 2019. PMID: 31623170 Free PMC article. - The impact of vancomycin trough concentrations on outcomes in non-deep seated infections: a retrospective cohort study.
Wan M, Walker SAN, Martin E, Elligsen M, Palmay L, Leis JA. Wan M, et al. BMC Pharmacol Toxicol. 2018 Jul 31;19(1):47. doi: 10.1186/s40360-018-0236-z. BMC Pharmacol Toxicol. 2018. PMID: 30064515 Free PMC article. - Phenotypic and Molecular Identification of Vancomycin Resistance in Clinical Staphylococcus Aureus Isolates in Osogbo, Nigeria.
Bamigboye BT, Olowe OA, Taiwo SS. Bamigboye BT, et al. Eur J Microbiol Immunol (Bp). 2018 Mar 9;8(1):25-30. doi: 10.1556/1886.2018.00003. eCollection 2018 Apr. Eur J Microbiol Immunol (Bp). 2018. PMID: 29760962 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous